Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET
2013-001143-31Phase 4Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in asthma comparing Small-particle ICS (ciclesonide) with Large-particle ICS (fluticasone propionate) (2 arms). Primary endpoint: Change in fractional exhaled nitric oxide (FeNO). Started Jun 2013; status: terminated.
02
Drugs
ciclesonidefluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-001143-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001143-31.